CoChat

Long-Term Weight Loss With Metformin or Lifestyle Intervention in the Diabetes Prevention Program Outcomes Study

Open access
Apolzan, John W., Venditti, Elizabeth M., Edelstein, Sharon L., Knowler, William C., Dabelea, Dana, Boyko, Edward J., Pi-Sunyer, Xavier, Kalyani, Rita R., Franks, Paul W., Srikanthan, Preethi, Gadde, Kishore M., for the Diabetes Prevention Program Research Group* · 2019 · Annals of Internal Medicine

The DOI matches its Crossref record; 54 of the 58 references it cites were found in a registry or an index.

Abstract

Background: Identifying reliable predictors of long-term weight loss (LTWL) could lead to improved weight management. Objective: To identify some predictors of LTWL. Design: The DPP (Diabetes Prevention Program) was a randomized controlled trial that compared weight loss with metformin, intensive lifestyle intervention (ILS), or placebo. Its Outcomes Study (DPPOS) observed patients after the masked treatment phase ended. (ClinicalTrials.gov: NCT00004992 and NCT00038727). Setting: 27 DPP and DPPOS clinics. Participants: Of the 3234 randomly assigned participants, 1066 lost at least 5% of baseline weight in the first year and were followed for 15 years. Measurements: Treatment assignment, personal characteristics, and weight. Results: After 1 year, 289 (28.5%) participants in the metformin group, 640 (62.6%) in the ILS group, and 137 (13.4%) in the placebo group had lost at least 5% of their weight. After the masked treatment phase ended, the mean weight loss relative to baseline that was maintained between years 6 and 15 was 6.2% (95% CI, 5.2% to 7.2%) in the metformin group, 3.7% (CI, 3.1% to 4.4%) in the ILS group, and 2.8% (CI, 1.3% to 4.4%) in the placebo group. Independent predictors of LTWL included greater weight loss in the first year in all groups, older age and continued metformin use in the metformin group, older age and absence of either diabetes or a family history of diabetes in the ILS group, and higher fasting plasma glucose levels at baseline in the placebo group. Limitation: Post hoc analysis; examination of nonrandomized subsets of randomized groups after year 1. Conclusion: Among persons with weight loss of at least 5% after 1 year, those originally randomly assigned to metformin had the greatest loss during years 6 to 15. Older age and the amount of weight initially lost were the most consistent predictors of LTWL maintenance. Primary Funding Source: National Institutes of Health.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7326/m18-1605

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 2

  1. 2000, The Diabetes Prevention Program Research Group. Diabetes Care, 23, 1619
  2. Blanton CA, 1999, Proc Soc Exp Biol Med, 221, 153

Cited by

See all 156

Metadata

Authors
Apolzan, J. W., Venditti, E. M., Edelstein, S. L., Knowler, W. C., Dabelea, D., Boyko, E. J., Pi-Sunyer, X., Kalyani, R. R., Franks, P. W., Srikanthan, P., Gadde, K. M., & for the Diabetes Prevention Program Research Group*
Affiliations
  • Pennington Biomedical Research Center (US)
  • University of Pittsburgh Medical Center (US)
  • George Washington University (US)
  • National Institute of Diabetes and Digestive and Kidney Diseases (US)
  • Colorado School of Public Health (US)
  • VA Puget Sound Health Care System (US)
  • Columbia University College of Physicians and Surgeons, New York, New York (X.P.)
  • Johns Hopkins University (US)
  • Lund University (SE)
  • University of California, Los Angeles (US)
Venue
Annals of Internal Medicine
Published
2019-05-21
Volume
170
Issue
10
Pages
682-690
ISSN
  • 0003-4819 (ISSN-L)
  • 1539-3704
OpenAlex
W2942237347
Cited by
156
References
58
Citations by year
2026: 19 · 2025: 20 · 2024: 21 · 2023: 28 · 2022: 22 · 2021: 21 · 2020: 16 · 2019: 9
FWCI
13.80
Type
journal article
Language
en
Open access
Licence
www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
Locations
  • Annals of Internal Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institute of Diabetes and Digestive and Kidney Diseases (U01 DK048489)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
Keywords
long-term weight loss, metformin, intensive lifestyle intervention, prediabetes, type 2 diabetes prevention, fasting blood glucose, age, family history of diabetes, Diabetes Prevention Program Outcomes Study
MeSH terms
Diabetes Mellitus, Type 2, Female, Humans, Hypoglycemic Agents, Life Style, Male, Metformin, Middle Aged, United States, Weight Loss

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.